The impact of radiotherapy costs on clinical outcomes in breast cancer

Radiotherapy and Oncology

Volumn 117, Issue 2, 2015, Pages 393-399

  Boero, Isabel J ^a   Paravati, Anthony J ^a   Triplett, Daniel P ^a   Hwang, Lindsay ^a   Matsuno, Rayna K ^a   Mell, Loren K ^a   Murphy, James D ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Breast cancer; Costs; Outcomes; Radiation therapy

Indexed keywords

AGED; ARTICLE; BRACHIAL PLEXOPATHY; BREAST CANCER; BREAST SURGERY; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CARDIOTOXICITY; CONTROLLED STUDY; COST BENEFIT ANALYSIS; FEMALE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MEDICARE; NEUROPATHY; PRIORITY JOURNAL; RADIATION INJURY; RADIATION PNEUMONIA; REIMBURSEMENT; RIB FRACTURE; SKIN TOXICITY; TREATMENT OUTCOME; BREAST NEOPLASMS; ECONOMICS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; TREATMENT OUTCOME;

EID: 84952636781     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2015.10.004     Document Type: Article

References (36)

1. Y. Yamada Cancer rehabilitation: principles and practice 2009 Demos Medical Publishing New York, NY
2. Early Breast Cancer Trialists' Collaborative Group, S. Darby, P. McGale, and et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials Lancet 378 2011 1707 1716
3. M. Clarke, R. Collins, S. Darby, and et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials Lancet 366 2005 2087 2106
4. K.B. Roberts, P.R. Soulos, J. Herrin, and et al. The adoption of new adjuvant radiation therapy modalities among Medicare beneficiaries with breast cancer: clinical correlates and cost implications Int J Radiat Oncol Biol Phys 85 2013 1186 1192
5. B.D. Smith, I.W. Pan, Y.C. Shih, and et al. Adoption of intensity-modulated radiation therapy for breast cancer in the United States J Natl Cancer Inst 103 2011 798 809
6. A.B. Mariotto, K.R. Yabroff, Y. Shao, E.J. Feuer, and M.L. Brown Projections of the cost of cancer care in the United States: 2010-2020 J Natl Cancer Inst 103 2011 117 128
7. A. Alhassani, A. Chandra, and M.E. Chernew The sources of the SGR "hole" N Engl J Med 366 2012 289 291
8. A.J. Paravati, B. Xu, L.K. Mell, and J.D. Murphy Sources of variation in the cost of radiation therapy for breast, lung, and prostate cancer Int J Radiat Oncol 90 2014 S63
9. R. Leary, and D.E. Farley APCs: reimbursement implications Healthc Financ Manage 54 2000 38 44
10. R.A. Deyo, D.C. Cherkin, and M.A. Ciol Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases J Clin Epidemiol 45 1992 613 619
11. J.L. Warren, L.C. Harlan, A. Fahey, and et al. Utility of the SEER-Medicare data to identify chemotherapy use Med Care 40 2002 VI-55 VI-61
12. M. Florescu, M. Cinteza, and D. Vinereanu Chemotherapy-induced cardiotoxicity Maedica 8 2013 59 67
13. B.A. Virnig, J.L. Warren, G.S. Cooper, C.N. Klabunde, N. Schussler, and J. Freeman Studying radiation therapy using SEER-Medicare-linked data Med Care 40 2002 VI-49 VI-54
14. A. Montero, X. Sanz, R. Hernanz, and et al. Accelerated hypofractionated breast radiotherapy: FAQs (Frequently Asked Questions) and facts Breast 23 2014 299 309
15. J. White, and M. Joiner Toxicity from radiation in breast cancer W. Small Jr. G. Woloschak, Radiation toxicity: a practical guide vol. 128 2006 Springer US 65 109
16. R. Roychoudhuri, H. Evans, D. Robinson, and H. Moller Radiation-induced malignancies following radiotherapy for breast cancer Br J Cancer 91 2004 868 872
17. L.M. Morton, E.S. Gilbert, P. Hall, and et al. Risk of treatment-related esophageal cancer among breast cancer survivors Ann Oncol 23 2012 3081 3091
18. B.D. Smith, C.P. Gross, G.L. Smith, D.H. Galusha, J.E. Bekelman, and B.G. Haffty Effectiveness of radiation therapy for older women with early breast cancer J Natl Cancer Inst 98 2006 681 690
19. M.R. Gold, J.E. Siegel, L.B. Russell, and M.C. Weinstein Cost-effectiveness in health and medicine 1996 Oxford University Press
20. M.L. Brown, G.F. Riley, N. Schussler, and R. Etzioni Estimating health care costs related to cancer treatment from SEER-Medicare data Med Care 40 2002 104 117
21. J.L. Warren, K.R. Yabroff, A. Meekins, M. Topor, E.B. Lamont, and M.L. Brown Evaluation of trends in the cost of initial cancer treatment J Natl Cancer Inst 100 2008 888 897
22. Centers for Medicare and Medicaid Services. National physician fee schedule and relative value files, vol. 2014; 2014.
23. Centers for Medicare & Medicaid Services. Market basket data. Baltimore, MD; 2014.
24. P.F. Jason, and R.J. Gray A proportional hazards model for the subdistribution of a competing risk J Am Statist Assoc 94 1999 496 509
25. S. Teckie, S.A. McCloskey, and M.L. Steinberg Value: a framework for radiation oncology J Clin Oncol 32 2014 2864 2870
26. C. Min, E. Connolly, T. Chen, G. Jozsef, and S.C. Formenti Hypofractionated radiation therapy for early stage breast cancer: outcomes, toxicities, and cost analysis Breast J 20 2014 267 273
27. J.E. Bekelman, G. Sylwestrzak, J. Barron, and et al. Uptake and costs of hypofractionated vs conventional whole breast irradiation after breast conserving surgery in the United States, 2008-2013 JAMA 312 2014 2542 2550
28. J.S. Haviland, J.R. Owen, J.A. Dewar, and et al. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials Lancet Oncol 14 2013 1086 1094
29. N. Lalani, L. Paszat, R. Sutradhar, and et al. Long-term outcomes of hypofractionation versus conventional radiation therapy after breast-conserving surgery for ductal carcinoma in situ of the breast Int J Radiat Oncol Biol Phys 90 2014 1017 1024
30. M.B. Mukesh, G.C. Barnett, J.S. Wilkinson, and et al. Randomized controlled trial of intensity-modulated radiotherapy for early breast cancer: 5-year results confirm superior overall cosmesis J Clin Oncol 31 2013 4488 4495
31. J.P. Pignol, I. Olivotto, E. Rakovitch, and et al. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis J Clin Oncol 26 2008 2085 2092
32. M.W. McDonald, K.D. Godette, E.K. Butker, L.W. Davis, and P.A. Johnstone Long-term outcomes of IMRT for breast cancer: a single-institution cohort analysis Int J Radiat Oncol Biol Phys 72 2008 1031 1040
33. P.S. Hussey, S. Wertheimer, and A. Mehrotra The association between health care quality and cost: a systematic review Ann Intern Med 158 2013 27 34
34. L. Steingisser, B. Acker, S. Berman, and et al. Bending the cost curve: a unique collaboration between radiation oncologists and Blue Cross Blue Shield of Massachusetts to optimize the use of advanced technology J Oncol Pract 10 2014 e321 327
35. H. Bartelink, J.C. Horiot, P.M. Poortmans, and et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial J Clin Oncol 25 2007 3259 3265
36. S.C. Darby, M. Ewertz, P. McGale, and et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer N Engl J Med 368 2013 987 998